These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21484981)

  • 21. Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice.
    Flavell DJ; Warnes SL; Noss AL; Flavell SU
    Br J Cancer; 2000 Dec; 83(12):1755-61. PubMed ID: 11104577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implications for trials of diabetes prevention in humans.
    Valorani MG; Hawa MI; Buckley LR; Afeltra A; Cacciapaglia F; Pozzilli P
    Diabetes Metab Res Rev; 2004; 20(5):394-8. PubMed ID: 15343585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus.
    Gearon CL; Hussain MJ; Vergani D; Peakman M
    Diabetologia; 1997 Dec; 40(12):1388-95. PubMed ID: 9447945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-asialo GM1 antibody suppression of cyclophosphamide-induced diabetes in NOD mice.
    Maruyama T; Watanabe K; Takei I; Kasuga A; Shimada A; Yanagawa T; Kasatani T; Suzuki Y; Kataoka K; Saruta
    Diabetes Res; 1991 May; 17(1):37-41. PubMed ID: 1823558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy with ciamexon in the non obese diabetic (NOD) mouse.
    Krug J; Lampeter EF; Williams AJ; Procaccini E; Cartledge C; Signore A; Beales PE; Pozzilli P
    Horm Metab Res; 1992 Jan; 24(1):1-4. PubMed ID: 1612551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
    J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperalgesia in non-obese diabetic (NOD) mice: a role for the inducible bradykinin B1 receptor.
    Gabra BH; Sirois P
    Eur J Pharmacol; 2005 May; 514(1):61-7. PubMed ID: 15878325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal dietary n-6/n-3 fatty acid ratio affects type 1 diabetes development in the offspring of non-obese diabetic mice.
    Kagohashi Y; Abiru N; Kobayashi M; Hashimoto M; Shido O; Otani H
    Congenit Anom (Kyoto); 2010 Dec; 50(4):212-20. PubMed ID: 20846138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes.
    Hayward AR; Shreiber M
    J Immunol; 1989 Sep; 143(5):1555-9. PubMed ID: 2527266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
    Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
    Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.
    Maron R; Guerau-de-Arellano M; Zhang X; Weiner HL
    J Autoimmun; 2001 Feb; 16(1):21-8. PubMed ID: 11221993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated BCG vaccination is more effective than a single dose in preventing diabetes in non-obese diabetic (NOD) mice.
    Shehadeh N; Etzioni A; Cahana A; Teninboum G; Gorodetsky B; Barzilai D; Karnieli E
    Isr J Med Sci; 1997 Nov; 33(11):711-5. PubMed ID: 9434805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
    Maron R; Melican NS; Weiner HL
    J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1.
    Nakazawa T; Satoh J; Takahashi K; Sakata Y; Ikehata F; Takizawa Y; Bando SI; Housai T; Li Y; Chen C; Masuda T; Kure S; Kato I; Takasawa S; Taniguchi T; Okamoto H; Toyota T
    J Autoimmun; 2001 Sep; 17(2):119-25. PubMed ID: 11591120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.
    Ogawa N; Minamimura K; Kodaka T; Maki T
    J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of type 1 diabetes by inducing subclinical dermatitis on a small area.
    Engkilde K; Johansen JD; Hansen AK; Menné T; Buschard K
    Diabetes Metab Res Rev; 2011 Nov; 27(8):954-8. PubMed ID: 22069292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic mice.
    Mehta DS; Christmas RA; Waldmann H; Rosenzweig M
    Immunology; 2010 May; 130(1):103-13. PubMed ID: 20059577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain.
    Kuhn C; Rezende RM; da Cunha AP; Valette F; Quintana FJ; Chatenoud L; Weiner HL
    J Autoimmun; 2017 Jan; 76():115-122. PubMed ID: 27745778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of berberine on serum glucose levels in non-obese diabetic mice.
    Chueh WH; Lin JY
    Int Immunopharmacol; 2012 Mar; 12(3):534-8. PubMed ID: 22266065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.